The economic burden of asthma and the role of co-morbidities

Project number: 
15-153
Approval date: 
Thursday, November 5, 2015
Principal Investigator: 
Sadatsafavi,Mohsen
Institution: 
University of British Columbia (UBC)
Funding Agency: 
Not Available
Datasets requested: 
Consolidation registry (Ministry of Health)
Deaths (BC Vital Statistics Agency)
Consolidation file (BC Ministry of Health)
Consolidation - demographic (Ministry of Health)
PharmaNet
Medical Services Plan (BC Ministry of Health)
consolidation - census geocodes
Hospital Separations (BC Ministry of Health)
Research objective: 

Objectives:

1) Estimate the excess costs of asthma in BC;

2) Estimate the excess costs of co-morbidities in patients with asthma;

3) Estimate the trend in the excess costs of cost of asthma over time;

4) Estimate the contribution of inpatient, outpatient, and medication costs to the excess economic burden of asthma and their co-morbidities.

Hypotheses:

1. Compared to the general population, individuals with asthma incur more excess direct medical costs due to co-morbidities than individuals without asthma;

2. The overall excess costs of asthma has increased in the province;

3. The per-patient cost of asthma has decreased.


Page last revised: December 5, 2017